Authors: Joice Farias do Nascimento | Flávia Oliveira Monteiro da Silva Abreu | Taysse Holanda | Raquel Oliveira dos Santos Fontenelle | Júlio César Sousa Prado | Emmanuel Silva Marinho | Matheus Nunes da Rocha | Jesyka Macêdo Guedes | Bruno Coêlho Cavalcanti | Wesley Lyeverton Correia Ribeiro | Márcia Machado Marinho | Hélcio Silva dos Santos
Source: Pharmaceuticals (article, 2024-10-28)
Field: Materials Science — Materials Chemistry

Evaluation of Emulsification Techniques to Optimize the Properties of Chalcone Nanoemulsions for Antifungal Applications <b>Background/Objectives:</b> Nanoemulsions (NEs) possess properties that enhance the solubility, bioavailability and therapeutic efficacy of drugs. Chalcones are compounds known for their antifungal properties. In this study, we evaluated different emulsification techniques to create alginate nanoemulsions containing chalcone (1E,4E)-1,5-bis (4-methoxyphenyl) penta-1,4-dien-3-one (DB4OCH<sub>3</sub>). Our goal was to develop an antifungal formulation targeting <i>Candida albicans</i> strains. <b>Methods:</b> Ultrasound and ultrasound combined with high-speed homogenization techniques were used to prepare alginate-stabilized nanoemulsions. Particle size, zeta potential and encapsulation efficiency were evaluated. Additionally, in vitro release studies were conducted. <b>Results:</b> The combined emulsification technique produced stable nanoparticles with high encapsulation efficiency and antifungal activity, with a minimum inhibitory concentration of 8.75 μg/mL for the nanoemulsions compared to 312 µg/mL for free DB4OCH<sub>3</sub>. NEs' effectiveness can be attributed to their ability to form nanodroplets efficiently, facilitating the solubilization of the chalcone in the oily phase. The particle size varied between 195.70 ± 2.69 and 243.40 ± 4.49 nm, with an increase in chalcone concentration leading to larger particle sizes. The zeta potential showed values from -91.77 ± 5.58 to -76.90 ± 4.44 mV. The UHS-7 sample exhibited an encapsulation efficiency of 92.10% ± 0.77, with a controlled in vitro release of 83% after 34 h. Molecular docking simulations showed that the aromatic nature of DB4OCH<sub>3</sub> resulted in the formation of apolar interactions with aromatic residues located in the active site of the TMK, as observed in their respective co-crystallized inhibitors, within an affinity energy range that enables optimum specificity of the ligand for these two pathways. Pharmacokinetic analyses indicated high passive cell permeability and low hepatic clearance, and phase I metabolism reduces its oral bioavailability and metabolic stability, suggesting a promising active ingredient as an oral drug with control of the daily oral dose administered. <b>Conclusions:</b> The combined nanoemulsification technique led to the formation of finely dispersed nanodroplets that favored the solubilization of the chalcone in the oil phase, which led to a better performance in the antifungal properties. DB4OCH<sub>3</sub> shows promise as an oral drug with controlled dosing. Antifungal ; Chalcone ; Chemistry ; Computer science ; Nanotechnology ; Biochemical engineering ; Materials science ; Medicine ; Dermatology ; Organic chemistry ; Engineering Nanoparticles: synthesis and applications ; Bee Products Chemical Analysis ; Nanocomposite Films for Food Packaging